Arimidex to get 2nd indication as early breast cancer treatment.

Published: 2003-04-10 06:56:00
Updated: 2003-04-10 06:56:00
The KFDA authorized Astra Zeneca's Arimidex (anastrozol) on April 4 for the early breast cancer treatment in addition to its original claims of the advancing breast cancer after menopause.

Arimidex, a 3rd generation of aromatase inhibitor, was indicated for the treatment of early breast cance...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.